Reddy D S, Singh M, Ghosh S, Ganguly N K
Department of Pharmacology, Panjab University, Chandigarh, India.
Mol Cell Biochem. 1996 Feb 9;155(1):1-11. doi: 10.1007/BF00714327.
Possible involvement of cardiac renin-angiotensin system (RAS) in pressure overload induced left ventricular hypertrophy (LVH) was investigated. Rats were subjected to abdominal aortic constriction (AAC) and examined the effects of 4 weeks treatments with an angiotensin converting enzyme (ACE) inhibitor, captopril and a vasodilator, hydralazine on haemodynamics and ventricular RNA, DNA, protein and myosin isoform pattern in sham and hypertrophied rats. AAC increased the mean arterial pressure (MAP) and systolic blood pressure (SBP), and resulted in increased left ventricle/body weight ratio, LV thickness, RNA and protein content, however total DNA was not changed. The expression of fetal isogene, beta-myosin heavy chain (beta-MHC), was markedly enhanced where as alpha-MHC was reduced. High-dose captopril (100 mg/kg p.o.,) significantly prevented the increase in haemodynamics, development of LVH, LV remodeling, increase in total protein, RNA and antithetical expression of myosin isoforms. Hydralazine (15 mg/kg p.o.,), did not modulate hypertrophic changes and low-dose captopril (1.5 mg/kg p.o.,) which has not produced any marked fall in MAP and SBP also modulated favourably the development of LVH and its biochemical markers. Thus, the prevention of the development of LVH and induction of beta-MHC by non-hypotensive doses of captopril may be related to the blockade of intracardiac production of angiotensin II rather than circulating system. These results suggest that cardiac RAS may play an important role in pressure overload induced LVH.
研究了心脏肾素-血管紧张素系统(RAS)在压力超负荷诱导的左心室肥厚(LVH)中的可能作用。对大鼠进行腹主动脉缩窄(AAC),并研究了用血管紧张素转换酶(ACE)抑制剂卡托普利和血管扩张剂肼屈嗪对假手术组和肥厚组大鼠进行4周治疗后对血流动力学以及心室RNA、DNA、蛋白质和肌球蛋白同工型模式的影响。AAC使平均动脉压(MAP)和收缩压(SBP)升高,并导致左心室/体重比、左心室厚度、RNA和蛋白质含量增加,但总DNA未改变。胎儿同工基因β-肌球蛋白重链(β-MHC)的表达明显增强,而α-MHC减少。高剂量卡托普利(100mg/kg口服)显著阻止了血流动力学的增加、LVH的发展、左心室重塑、总蛋白和RNA的增加以及肌球蛋白同工型的反向表达。肼屈嗪(15mg/kg口服)未调节肥厚性变化,低剂量卡托普利(1.5mg/kg口服)未使MAP和SBP出现明显下降,但也对LVH的发展及其生化标志物产生了有利调节作用。因此,非降压剂量的卡托普利预防LVH的发展和诱导β-MHC可能与阻断心脏内血管紧张素II的产生有关,而不是与循环系统有关。这些结果表明,心脏RAS可能在压力超负荷诱导的LVH中起重要作用。